61
Views
0
CrossRef citations to date
0
Altmetric
Case Report

Multi-Omics Characterization and Origin Assessment of Bilateral Lung Adenoid Cystic Carcinoma: A Case Report

, , , ORCID Icon &
Pages 1981-1987 | Published online: 25 Feb 2021

References

  • Chaudhry AP, Leifer C, Cutler LS, Satchidanand S, Labay GR, Yamane GM. Histogenesis of adenoid cystic carcinoma of the salivary glands. Light and electron microscopic study. Cancer. 1986;58(1):72–82. doi:10.1002/1097-0142(19860701)58:1<72::AID-CNCR2820580114>3.0.CO;2-Q3011238
  • Lawrence JB, Mazur MT. Adenoid cystic carcinoma: a comparative pathologic study of tumors in salivary gland, breast, lung, and cervix. Hum Pathol. 1982;13(10):916–924. doi:10.1016/S0046-8177(82)80052-X6290368
  • Travis WD, Brambilla E, Nicholson AG, et al. The 2015 World Health Organization classification of lung tumors: impact of genetic, clinical and radiologic advances since the 2004 classification. J Thorac Oncol. 2015;10(9):1243–1260. doi:10.1097/JTO.000000000000063026291008
  • Travis WD, Travis LB, Devesa SS. Lung cancer. Cancer. 1995;75(1 Suppl):191–202.8000996
  • Kawashima O, Hirai T, Kamiyoshihara M, Ishikawa S, Morishita Y. Primary adenoid cystic carcinoma in the lung: report of two cases and therapeutic considerations. Lung Cancer. 1998;19(3):211–217. doi:10.1016/S0169-5002(97)00098-69631369
  • Inoue H, Iwashita A, Kanegae H, Higuchi K, Fujinaga Y, Matsumoto I. Peripheral pulmonary adenoid cystic carcinoma with substantial submucosal extension to the proximal bronchus. Thorax. 1991;46(2):147–148. doi:10.1136/thx.46.2.1471849668
  • Szpak-Ulczok S, Pfeifer A, Rusinek D, et al. Differences in gene expression profile of primary tumors in metastatic and non-metastatic papillary thyroid carcinoma-do they exist? Int J Mol Sci. 2020;21(13):4629. doi:10.3390/ijms21134629
  • Chang JC, Alex D, Bott M, et al. Comprehensive next-generation sequencing unambiguously distinguishes separate primary lung carcinomas from intrapulmonary metastases: comparison with standard histopathologic approach. Clin Cancer Res. 2019;25(23):7113–7125. doi:10.1158/1078-0432.CCR-19-170031471310
  • Li Y, Krahn JM, Flake GP, Umbach DM, Li L. Toward predicting metastatic progression of melanoma based on gene expression data. Pigment Cell Melanoma Res. 2015;28(4):453–463. doi:10.1111/pcmr.1237425847062
  • Tan B, Jiang X, Wang R, et al. Genomic profiling reveals synchronous bilateral lung adenocarcinomas with distinct driver alterations of EML4-ALK or TPM3-ROS1 fusion: a case report. Front Oncol. 2019;9:1319. doi:10.3389/fonc.2019.0131931828041
  • Costa C, Engelman JA. The double life of p85. Cancer Cell. 2014;26(4):445–447. doi:10.1016/j.ccell.2014.09.01125314071
  • Lu Y, Lemon W, Liu PY, et al. A gene expression signature predicts survival of patients with stage I non-small cell lung cancer. PLoS Med. 2006;3(12):e467. doi:10.1371/journal.pmed.003046717194181
  • Chen L, Yang L, Yao L, et al. Characterization of PIK3CA and PIK3R1 somatic mutations in Chinese breast cancer patients. Nat Commun. 2018;9(1):1357. doi:10.1038/s41467-018-03867-929636477
  • Schena M, Shalon D, Davis RW, Brown PO. Quantitative monitoring of gene expression patterns with a complementary DNA microarray. Science. 1995;270(5235):467–470. doi:10.1126/science.270.5235.4677569999
  • Bakin AV, Tomlinson AK, Bhowmick NA, Moses HL, Arteaga CL. Phosphatidylinositol 3-kinase function is required for transforming growth factor beta-mediated epithelial to mesenchymal transition and cell migration. J Biol Chem. 2000;275(47):36803–36810. doi:10.1074/jbc.M00591220010969078
  • Porta C, Paglino C, Mosca A. Targeting PI3K/Akt/mTOR signaling in cancer. Front Oncol. 2014;4:64. doi:10.3389/fonc.2014.0006424782981
  • Bonner Millar LP, Stripp D, Cooper JD, Both S, James P, Rengan R. Definitive radiotherapy for unresected adenoid cystic carcinoma of the trachea. Chest. 2012;141(5):1323–1326. doi:10.1378/chest.11-092522553266